Wed, February 4, 2009
Tue, February 3, 2009
Mon, February 2, 2009
Sun, February 1, 2009
Sat, January 31, 2009
Fri, January 30, 2009
[ Fri, Jan 30th 2009 ]: Market Wire
Progen-Avexa Merger Update
Thu, January 29, 2009
Wed, January 28, 2009
Tue, January 27, 2009
[ Tue, Jan 27th 2009 ]: Market Wire
SCOR: SCOR sets up Zurich Hub
Mon, January 26, 2009
Sun, January 25, 2009
Fri, January 23, 2009
Thu, January 22, 2009
Wed, January 21, 2009

Seattle Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Year 2008 Financial Results on February 5


  Copy link into your clipboard //health-fitness.news-articles.net/content/2009/ .. d-year-2008-financial-results-on-february-5.html
  Print publication without navigation Published in Health and Fitness on , Last Modified on 2009-01-29 07:46:58 by Market Wire
          🞛 This publication is a summary or evaluation of another publication

BOTHELL, Wash.--([ BUSINESS WIRE ])--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that it will report its fourth quarter and year 2008 financial results on Thursday, February 5, 2009, after the close of financial markets. Following the announcement, company management will host a conference call and webcast discussion of the results and provide a general corporate update. Access to the event can be obtained as follows:

LIVE access on Thursday, February 5, 2009, 2:00 p.m. Pacific Time (PT) / 5:00 p.m. Eastern Time (ET)

  • Telephone (800) 257-3401 (domestic) or (303) 242-0001 (international)
  • Webcast available at [ www.seattlegenetics.com ] in the News and Investor Information section

REPLAY access

  • Telephone replay will be available beginning at approximately 4:00 p.m. PT on February 5, 2009 through 4:00 p.m. PT on February 9, 2009 by calling (800) 405-2236 (domestic) or (303) 590-3000 (international); passcode 11125657
  • Webcast replay will be available on the Seattle Genetics website at [ www.seattlegenetics.com ] in the News and Investor Information section

Seattle Genetics is a clinical stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease.


Publication Contributing Sources

Similar Health and Fitness Publications